Hjem › Amyloidose › Texas
Amyloidose kliniske forsøg i Texas
11 studier for Amyloidose søger deltagere på steder i Texas.
Byer i Texas
Officiel studietekst (engelsk)
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis
- MD Anderson Cancer Center, Houston
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT05652335Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
- Research Site, Dallas
- Research Site, Houston
RekruttererObservationsstudie
Alder 18 til 130 · Alle køn · Opdateret 23. sep. 2026 · NCT06465810TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
- Clinical Trial Site, Austin
- Clinical Trial Site, Dallas
- Clinical Trial Site, Houston
- og 1 flere
RekruttererFase 3
Alder 18 til 85 · Alle køn · Opdateret 16. sep. 2026 · NCT07052903TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy
- Clinical Trial Site, Dallas
- Clinical Trial Site, Houston
RekruttererFase 3
Alder 18 til 85 · Alle køn · Opdateret 15. sep. 2026 · NCT07223203DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World Setting
- Clinical Trial Site, Dallas
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 9. sep. 2026 · NCT07358078ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)
- Clinical Trial Site, Austin
- Clinical Trial Site, Houston
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 8. sep. 2026 · NCT04561518Subclinical Transthyretin Cardiac Amyloidosis in V122I TTR Carriers
- University of Texas Southwestern Medical Center, Dallas
RekruttererObservationsstudie
Alder 30 til 80 · Alle køn · Opdateret 31. aug. 2026 · NCT05489549Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis
- UT Southwestern Medical Center, Dallas
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 19. aug. 2026 · NCT05145816Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- National Neuromuscular Research Institute, Austin
- University of Texas Southwestern, Dallas
RekruttererFase 3
Alder 18 til 75 · Alle køn · Opdateret 4. aug. 2026 · NCT06563895MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
- Baylor Scott & White Research Institute, Dallas
- University of Texas Southwestern Medical Center, Dallas
- Baylor College of Medicine, Houston
- og 2 flere
RekruttererFase 3
Alder 18 til 90 · Alle køn · Opdateret 27. mar. 2026 · NCT06128629Determining the Association of TTR Stabilizing Therapy With Circulating TTR Amyloid Aggregates Over Time in Patients With ATTR-CM: Longitudinal Biomarker Study
- UT Southwestern Medical Center, Dallas
RekruttererObservationsstudie
Alder 30 til 80 · Alle køn · Opdateret 7. jan. 2026 · NCT07196839Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.